TY  - GEN
AU  - Heal,D J
AU  - Gosden,J
AU  - Smith,S L
TI  - A review of late-stage CNS drug candidates for the treatment of obesity
SN  - 1476-5497
PY  - 2013///0624
KW  - Anti-Obesity Agents
KW  - administration & dosage
KW  - Bupropion
KW  - pharmacology
KW  - Central Nervous System Stimulants
KW  - Drug Administration Schedule
KW  - Drug Approval
KW  - Drug Combinations
KW  - Drug Design
KW  - Drugs, Investigational
KW  - Female
KW  - Guidelines as Topic
KW  - Humans
KW  - Male
KW  - Naltrexone
KW  - Obesity
KW  - drug therapy
KW  - Patient Selection
KW  - Phentermine
KW  - Receptor, Serotonin, 5-HT2C
KW  - drug effects
KW  - Risk Factors
KW  - Risk Reduction Behavior
KW  - United Kingdom
KW  - epidemiology
N1  - Publication Type: Journal Article; Review
UR  - https://doi.org/10.1038/ijo.2012.26
ER  -